Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Helium-Induced Early and Late Preconditioning (HELP) in Human Endothelium
2007-006233-14Phase 2Completed
- Sponsor
- Academic Medical Center
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of heliox21, sponsored by Academic Medical Center. Primary endpoints: Forearm blood flow response to ischemia-reperfusion with endothelium-dependent vasodilation and Forearm blood flow response to ischemia-reperfusion with endothelium-independent vasodilation. Started Nov 2007; status: completed.
02
Drugs
heliox21
Beyond the preview
Go deeper on 2007-006233-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006233-14.